Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
PFIZER Inc and Abbott Laboratories on Monday said they would comply with a ban on a popular cough syrup in India after it was added to a local list of prohibited drugs, sending shares in the US firms' Indian subsidiaries tumbling.
Pfizer's Corex-brand syrup and Abbott's